Suppr超能文献

静脉注射磷酸丙吡胺及心室超速起搏用于终止阵发性室性心动过速

Intravenous disopyramide phosphate and ventricular overdrive pacing in the termination of paroxysmal ventricular tachycardia.

作者信息

Camm J, Ward D, Washington H G, Spurrell R A

出版信息

Pacing Clin Electrophysiol. 1979 Jul;2(4):395-402. doi: 10.1111/j.1540-8159.1979.tb05215.x.

Abstract

Both antiarrhythmic drugs and bursts of rapid ventricular pacing provide alternatives to DC cardioversion for the treatment of paroxysmal ventricular tachycardia. This report considers the individual and combined success of burst ventricular pacing and intravenous disopyramide phosphate in the tretment of 11 examples of paroxysmal ventricular tachycardia. Rapid ventricular pacing, at a rate of up to 50 beats/min faster than the tachycardia rate terminated 7 of the tachycardias. Intravenous disopyramide resulted in increased tachycardiac cycle length (342 +/- 34 ms-385 +/- 56 ms), increased QRS complex width (147 +/- 42 ms-180 +/- 41 ms) and termination of 8 the tachycardias. The remaining 3 tachycardias could be terminated by bursts of ventricular pacing following the infusion of disopyramide. Of these, 2 could not be terminated prior to disopyramide. The use of both techniques allowed the extinction of all 11 tachycardias and prevented the need to proceed to DC conversion.

摘要

抗心律失常药物和快速心室起搏阵发都为治疗阵发性室性心动过速提供了直流电复律的替代方法。本报告探讨了阵发心室起搏和静脉注射磷酸丙吡胺在治疗11例阵发性室性心动过速中的单独及联合应用效果。快速心室起搏,频率比心动过速快50次/分钟,终止了7例心动过速。静脉注射丙吡胺导致心动过速周期长度增加(342±34毫秒至385±56毫秒),QRS波群宽度增加(147±42毫秒至180±41毫秒),并终止了8例心动过速。其余3例心动过速可在输注丙吡胺后通过阵发心室起搏终止。其中,2例在使用丙吡胺之前无法终止。两种技术的联合应用使所有11例心动过速得以终止,并避免了进行直流电转换的必要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验